The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity. ” .”

Diversity 101

Diversity Innovation Biotechnology Short-term 101

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

SEPTEMBER 23, 2014

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. They overcame short-term thinking. A majority of public companies pledge allegiance to short-term profit over long-term vision. But it does happen.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

SEPTEMBER 29, 2011

They are not interested in hearing about the technological, regulatory, and societal developments that will determine the long-term, strategic positioning of this company.". Some large investors already have a long-term view. CEOs can seek to attract long-term investors in several ways: 1.

Long-term 12

Long-term CEO Short-term Asset Management 12

Harvard Business Review

JULY 8, 2016

Xiaomi’s phones are not technologically disruptive in hardware terms, but they are revolutionary in customer experience terms; customers come to expect and appreciate their weekly OS updates. We spoke with several Chinese entrepreneurs in Kunshan last month — young and old, working in both the private sector and the public.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. from that of a fully integrated pharmaceutical company into a company that retained key technical expertise (e.g., Accordingly, I transformed the business model ?

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

SEPTEMBER 21, 2018

Boards’ abilities to foster innovation clearly fall short when compared with their other activities. Still, it’s telling that board members rate their boards better on risk management than on innovation. We also found that a focus on innovation tends to go hand in hand with longer-term time horizons.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

DECEMBER 14, 2017

This tends to focus doctors, nurses, and other health professionals on the value of what they do — finding the most cost-effective approach to managing their patients’ problems. The reason this formula works is that when care-delivery systems also act as insurers, they assume financial responsibility for the care they provide.

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 26, 2011

The stock market is short-term-oriented. Stock-based incentive compensation aligns the self-interest of management with shareholders, and a performance-based pay system increases employee motivation. In my experience, these beliefs have led managers and boards to take actions that have had unintended, destructive consequences.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Christensen has even re-entered the fold clarifying what he means when he uses the term. Is 23andMe potentially disruptive to pharmaceutical companies? ” One in ancestry and the other in drug development. .”

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

SEPTEMBER 14, 2017

A less aggressive mix (say 75:25) is typical in industries such as pharmaceuticals that want salespeople to focus on customer education, and for technical sales jobs that have a large problem-solving component. a high second number) motivates salespeople to drive short-term results.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

MARCH 14, 2017

When one of us (Vivek) and his team launched Roivant Sciences in 2014 and began developing treatments for Alzheimer’s disease — they were determined to learn from the pharma industry’s innovation issues and build a more sustainable innovation engine. Roivant’s first response was to address misaligned incentives.

Innovation 9

Innovation Company Incentives Industry 9

Harvard Business Review

JUNE 27, 2012

Paul is an old friend who, until his recent retirement, worked as a senior scientist at a pharmaceutical company, where he managed a group of innovative researchers. Because of the start-up's success in developing drugs, it was acquired by a large multinational company.

COO 11

COO Short-term Pharmaceuticals Innovation 11

Harvard Business Review

AUGUST 14, 2018

The term “digital firms” refers to those companies that from their inception have focused on digital services enabled by the internet and related technologies, including mobile. poor management of relations with Chinese regulators and the government. failure to manage relations effectively with local business partners.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

SEPTEMBER 5, 2016

The UK’s Department for International Development uses “results-based” aid to improve the educational outcomes of young girls in Africa and Asia. Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 29, 2015

At the same time, there are certain ways LBOs can actually make it easier for firms to invest in the long term. Because of their relationships with banks, PE funds can get financing much cheaper than target companies could under their current management. LBOs can help firms that are financially constrained invest in innovation.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. However, equally rare is tapping into the minds of a group of imaginative, open-minded employees and managers to scope out potential strategic opportunities. paul Garbett for HBR.

Leadership 10

Leadership Diversity Committee Long-term 10

Harvard Business Review

APRIL 24, 2017

and governments around the world to develop an equivalent to the Defense Advanced Research Projects Agency (DARPA), that focuses cross-sector efforts on advancing biological and pandemic risk readiness. and the global community can manage them. In short, we must adopt a global “invest now or pay later” economic philosophy.

Project 8

Project Disaggregation Globalization Comparison 8

Harvard Business Review

JUNE 20, 2017

Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication. A comprehensive internal data platform was developed to help Dr. Reddy’s employees be proactive with their customer requests and solve any problems in an agile way. Frame the issue.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

FEBRUARY 11, 2016

Google and Intel rely on experts in social science and biomechanics to develop transformative products by better understanding how people think about and use technology. Too often, purchasing departments manage the selection while operating managers—not involved in selection by fiat—are expected to make the relationship work.

Agility 8

Agility Organization Resources Fixed Costs 8

Harvard Business Review

OCTOBER 22, 2013

She kicked off her October management team meeting, which I was attending, by reading the following passage from my book: The dangers of taking too much risk are very clear. They develop slowly over time and are almost impossible to pinpoint. Risk management Strategy' We’re reminded of them in the news every day.

COO 8

COO Short-term CFO Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 5, 2013

With scarcely any help from management, knowledge workers can increase their productivity by 20%. Yet here is the challenge you face as a senior executive: You cannot manage your knowledge workers in the traditional and intrusive way you might have done with manual workers.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

SEPTEMBER 20, 2013

Very importantly, they were able to avoid costly technology and implementation programs that would have surely fell short of usage and revenue expectations. Sometimes the revenue may be small in absolute terms, but the data capability may be complementary to your current, core business. Execution Knowledge management'

Execution 8

Execution Metrics Content Christensen 8

Harvard Business Review

FEBRUARY 4, 2013

In short, change would happen, but at a dangerously slow pace. Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Institutions.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Strategy Driven

OCTOBER 10, 2016

This doesn’t mean you have to cut your creativity short or make what should be lighter, enjoyable activities feel like they’re work. Not only does this exposure enhance employees’ perspectives and further their professional development, it also helps to fortify a consistent company-wide culture of service. What’s next?

Strategy 50

Strategy Pharmaceuticals Learning-by-Doing Outsourcing 50

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

NOVEMBER 20, 2015

But let’s change what we’re asking: Which has the better potential to scale up and create long term value for customers, owners, investors, and employees? Manage culture by setting expectations appropriately. Manage the arduously long sales cycle. No doubt the tech startup wins the popularity contest hands down.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MAY 10, 2013

As noted management expert Geoffrey Moore told me with respect to high-velocity competition, "I''m not sure you ever want to be in the public markets." Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms. So we are left with a quandary.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8

Harvard Business Review

NOVEMBER 22, 2013

Despite years of consumer research, the pharmaceutical firm hadn’t known about the staining problem. Corporate social-listening efforts are typically driven by econometricians, computer scientists, and IT technicians—the people who are expert in database management. But a lot of people in business don’t appreciate that.

Sample 9

Sample Competitive Advantage Pharmaceuticals Marketing 9

Harvard Business Review

MARCH 8, 2011

How will they develop the next generation of leaders, and groom them for challenges that can't yet be imagined? All too soon, however, the demands of managing the near-term business take over. In the short run, you'll see better financials. How thoroughly must they transform the company to make this happen?

Merchandising 14

Merchandising Budgeting Pharmaceuticals CEO 14

Harvard Business Review

JUNE 24, 2015

Managers and other business leaders face a dilemma: with increasingly diverse environments to manage and rising stakes to get it right, how do they identify the most effective approach to business strategy and marshal the right thinking and behaviors to conceive and execute it, supported by the appropriate frameworks and tools?

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

NOVEMBER 3, 2017

The team tasked with overseeing the effort designed an aggressive implementation plan that tied targets to manager compensation. However, beyond the strategic goal of becoming an industry leader in terms of cost structure, there was no “story” for how this effort would complement the business’s broader ambitions.

Execution 14

Execution Strategy Decentralization Short-term 14

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

MAY 12, 2011

Instead of a pharmaceutical industry, I see a new set of mental and physical discontents, like rates of suspiciously normally "abnormal" mental illnesses and drugs whose lists of "side effects" are longer than the Magna Carta. Gary Hamel , whose Future of Management is about creating the capacity to live better. Better, not just more.

GDP 21

GDP Hamel Industry Construction 21

Harvard Business Review

JUNE 20, 2017

While consumer spending has proven resilient, with same-store retail sales rising 6% YOY in April , most multinational corporations are developing contingency plans to mitigate risks to their businesses and reassessing the country’s role in their global market portfolio and supply chains. Renegotiating NAFTA.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8

Harvard Business Review

OCTOBER 8, 2013

And because it focuses on acute episodes, REBP acts as a necessary complement to payment and care-delivery models designed to improve prevention and chronic-care management. In short, REBP can serve as a bridge to more comprehensive total-cost-of-care approaches. pharmaceuticals, physical therapy, skilled nursing facility care).

Health Care 8

Health Care Cost Analysis Competitive Advantage 8